Legislative Proposal, Bill or Resolution, Regulation
Food and Drugs Act and Regulations, specifically with respect to the approval, regulation and life-cycle management of therapeutic products
Patent Act with respect to Canada's Access to Medicines Regime (ss. 21.01-21.09)
Policies or Program
Federal public drug plans, specifically the Non-Insured Health Benefits Program (Health Canada), with respect to decisions and policies that impact reimbursement of therapeutic products for plan beneficiaries
Health Canada's office of pharmaceutical management strategies, particularly as it relates to Health Canada's role in supporting and directing federal, national and inter-jurisdictional pharmaceutical policy
Innovation Agenda, particularly with respect to initiatives to support or attract investments in the the life sciences sector
Patented Medicine Prices Review Board with respect to the regulation of pricing of patented drug products
Policies or Program, Regulation
Health Canada policies with respect to authorization of subsequent entry biologics (SEBs) under the Food and Drugs Act and Regulations
Health Products and Food Regulatory Modernization, specifically related to the draft Orphan Drugs Regulatory Framework
Regulation
Food and Drugs Act Regulations with respect to Data Protection under C.08.004.
Patent Act Regulations as they relate to the regulation of intellectual property for therapeutic products, specifically the Patented Medicines (Notice of Compliance) Regulations.
Patent Act as it relates to the regulation of intellectual property for therapeutic products